drugset / Trial / NCT06532240
Methylene Blue for the Treatment of Septic Shock
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of methylene blue among adult patients with septic shock.
Timeline
- Start
- 2024-08-05
- Primary completion
- 2025-10-24
- Completion
- 2025-10-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylene Blue | Diagnostic / imaging agent | 0.25 mg/kg | Intravenous |